Treatment with the recently approved, minimally invasive Optilume BPH device improves urinary symptoms while preserving sexual function in men with benign prostatic hyperplasia (BPH), concludes a ...
Inflating a drug-coated balloon in the prostate is the latest approach to treating a common cause of frequent or difficult urination in older men. More recently, researchers have developed various ...
The US Food and Drug Administration has approved a new catheter designed to treat urinary tract symptoms of an enlarged prostate, also known as benign prostate hyperplasia (BPH). Designed and marketed ...
May 18—MORGANTOWN — Mon Health Medical Center achieved another first this month — becoming the first in the state to offer a novel, effective procedure for men with enlarged prostates. The condition ...
Dr. Steven A. Kaplan presented positive 4-year and 12-month clinical outcomes during the American Urological Association's Annual Meeting "The positive data from the PINNACLE and EVEREST trials – ...
LAS VEGAS -- A novel, non-ablative intervention for lower urinary tract symptoms (LUTS) produced rapid, durable symptom relief with no adverse effect on sexual function, long-term results from ...
Optilume BPH is expected to have a significant global impact in urology, offering a novel alternative treatment option for enlarged prostate "We are proud at University Urology Associates to be ...
Add Yahoo as a preferred source to see more of our stories on Google. May 18—MORGANTOWN — Mon Health Medical Center achieved another first this month — becoming the first in the state to offer a novel ...